Why the study?
The study evaluated the efficacy of Qianshan Huoxue Gao (QS) in treating acute coronary syndrome and explored its mechanism of action regarding intestinal flora regulation.
Does Qianshan Huoxue Gao improve cardiac function and reduce inflammation in a rat model of acute coronary syndrome?
Does Qianshan Huoxue Gao improve cardiac function and reduce inflammation in a rat model of acute coronary syndrome?
Qianshan Huoxue Gao improves cardiac function and reduces inflammation in a rat model of acute coronary syndrome, potentially via regulation of intestinal flora and ethanolamine metabolism.
Answers are grounded in this paper and cite their sources.
QS may benefit ACS via flora regulation; leaves open clinical translation from this rat model.
Purpose: To study the efficacy of Qianshan Huoxue Gao (QS) in treating acute coronary syndrome (ACS) and to explore the mechanism of action from the perspective of intestinal flora regulation. Methods: Male Sprague–Dawley rats were divided into control, model, QS, and atorvastatin groups; except for the control group, rats underwent ligation of the left anterior descending branch of the coronary artery. Following treatment for 28 days, cardiac function was evaluated using an echocardiographic assay; ELISAs for serum creatine kinase isoenzyme (CK-MB), cardiac troponin I (cTnI), high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-2 (IL-2), IL-6, and tumor necrosis factor-α (TNF-α); assessment of cardiac enzymes and inflammatory response; hematoxylin and eosin (HE) staining for histopathological changes in the heart, skin, and viscera; 16S rRNA gene sequencing for intestinal flora diversity and structural differences analysis; and we further investigated intestinal contents using metabolomics. Results: Compared with controls, CK-MB and cTnI were increased ( P < 0.01); ejection factor and fractional shortening were decreased ( P < 0.01); left ventricular internal end-diastolic dimension and left ventricular internal end-systolic dimension were increased ( P < 0.01); and IL-2, IL-6, TNF-α, and hs-CRP were increased in the model group. Myocardial damage and inflammation were also observed by HE staining. QS improved these indexes, similar to the atorvastatin group; therefore, QS could effectively treat ACS. QS modulates the structure and abundance of the intestinal flora in ACS model rats, among which Bacteroides, Lactobacillus , and Rikenellaceae_RC9_gut_group are associated with cardiovascular disease. Metabolomics revealed that the intestinal metabolite content changed in ACS, with ethanolamine (EA) being the most relevant metabolite for ACS treatment by QS. EA was significantly positively correlated with Eubacterium xylanophilum group, Ruminococcus, unclassified f__Oscillospiraceae, Intestinimonas, Eubacterium siraeum group, Lachnospiraceae NK4A136 group , and norank f__Desulfovibrionaceae . Conclusion: QS can effectively treat ACS and can restore regulation of the intestinal flora. EA may be the primary metabolite of QS, exerting a therapeutic effect in ACS.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: